Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)
China
· Delayed Price · Currency is CNY 22.96
+0.67 (3.01%)
Apr 28, 2026, 3:00 PM CST
SHA:600332 Revenue
Guangzhou Baiyunshan Pharmaceutical Holdings Company had revenue of 23.28B CNY in the quarter ending March 31, 2026, with 3.58% growth. This brings the company's revenue in the last twelve months to 78.46B, up 5.29% year-over-year. In the year 2025, Guangzhou Baiyunshan Pharmaceutical Holdings Company had annual revenue of 77.66B with 3.55% growth.
Revenue (ttm)
78.46B
Revenue Growth
+5.29%
P/S Ratio
0.45
Revenue / Employee
2.90M
Employees
27,057
Market Cap
35.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 77.66B | 2.66B | 3.55% |
| Dec 31, 2024 | 74.99B | -522.58M | -0.69% |
| Dec 31, 2023 | 75.52B | 4.73B | 6.68% |
| Dec 31, 2022 | 70.79B | 1.77B | 2.57% |
| Dec 31, 2021 | 69.01B | 7.34B | 11.90% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Jan 1, 2018 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jointown Pharmaceutical Group | 164.16B |
| Shanghai Pharmaceuticals Holding | 283.58B |
| China National Medicines Corporation | 53.31B |
| Liaoning Cheng Da | 9.90B |
| China Meheco Group | 35.36B |
| China National Accord Medicines Corporation | 72.95B |
| Qingdao Baheal Medical INC. | 7.58B |
| C.Q. Pharmaceutical Holding | 82.27B |